ADMA Biologics, Inc. (ADMA)

ADMA Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,335	4,054	1,021	857	276	184
Market Cap Growth	212.98%	296.93%	19.17%	210.44%	49.75%	-22.30%
Enterprise Value	4,346	4,079	1,100	975	343	225
Last Close Price	18.13	17.15	4.52	3.88	1.41	1.95
PE Ratio	21.69	20.51	-	-	-	-
Forward PE	22.81	25.28	36.16	-	-	-
PS Ratio	9.29	9.51	3.96	5.56	3.41	4.37
PB Ratio	11.58	11.62	7.55	5.64	1.96	2.09
P/TBV Ratio	11.74	11.75	7.79	5.81	2.03	2.24
P/FCF Ratio	47.83	36.71	253.51	-	-	-
P/OCF Ratio	42.83	34.16	116.07	-	-	-
EV/Sales Ratio	9.46	9.56	4.26	6.33	4.24	5.33
EV/EBITDA Ratio	27.17	27.74	33.58	-	-	-
EV/EBIT Ratio	28.58	29.35	45.03	-	-	-
EV/FCF Ratio	47.95	36.93	273.07	-	-	-
Debt / Equity Ratio	0.22	0.24	1.05	1.02	0.73	1.11
Debt / EBITDA Ratio	0.51	0.55	4.02	-	-	-
Debt / FCF Ratio	0.91	0.74	35.10	-	-	-
Asset Turnover	1.07	1.04	0.76	0.49	0.34	0.25
Inventory Turnover	1.25	1.21	1.00	0.83	0.77	0.80
Quick Ratio	3.20	2.76	1.58	2.60	2.62	3.47
Current Ratio	6.58	5.97	5.16	6.89	6.87	7.71
Return on Equity (ROE)	78.45%	81.64%	-19.67%	-44.96%	-62.46%	-132.38%
Return on Assets (ROA)	22.06%	21.24%	4.51%	-7.88%	-14.87%	-21.44%
Return on Capital (ROIC)	25.32%	24.55%	5.24%	-8.94%	-16.74%	-24.18%
Return on Capital Employed (ROCE)	33.30%	32.10%	8.70%	-	-	-
Earnings Yield	4.77%	4.88%	-2.77%	-7.69%	-25.95%	-41.09%
FCF Yield	2.09%	2.72%	0.39%	-8.57%	-45.59%	-62.23%
Buyback Yield / Dilution	-8.72%	-8.65%	-13.19%	-41.77%	-62.03%	-58.51%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q